2022 Q1 Form 10-Q Financial Statement

#000184606922000024 Filed on May 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021 Q1
Revenue $51.00M $192.2M $34.39M
YoY Change 48.31%
Cost Of Revenue $9.055M $28.81M $6.337M
YoY Change 42.89%
Gross Profit $41.95M $163.4M $28.05M
YoY Change 49.54%
Gross Profit Margin 82.25% 85.01% 81.57%
Selling, General & Admin $46.21M $158.6M $32.22M
YoY Change 43.41%
% of Gross Profit 110.17% 97.08% 114.88%
Research & Development $28.96M $97.10M $20.82M
YoY Change 39.1%
% of Gross Profit 69.04% 59.43% 74.22%
Depreciation & Amortization $1.330M $4.172M $1.083M
YoY Change 22.81%
% of Gross Profit 3.17% 2.55% 3.86%
Operating Expenses $75.17M $255.5M $53.04M
YoY Change 41.72%
Operating Profit -$33.23M -$92.15M -$24.99M
YoY Change 32.94%
Interest Expense $491.0K $166.4K -$13.59M
YoY Change -103.61%
% of Operating Profit
Other Income/Expense, Net -$185.0K $9.749M -$148.0K
YoY Change 25.0%
Pretax Income -$32.92M -$82.24M -$25.10M
YoY Change 31.15%
Income Tax $28.00K $157.0K $39.00K
% Of Pretax Income
Net Earnings -$32.95M -$82.39M -$25.14M
YoY Change 31.06%
Net Earnings / Revenue -64.6% -42.87% -73.11%
Basic Earnings Per Share -$0.09 -$0.26
Diluted Earnings Per Share -$0.09 -$563.0K -$0.26
COMMON SHARES
Basic Shares Outstanding 381.9M shares 97.87M shares
Diluted Shares Outstanding 381.9M shares 97.87M shares

Balance Sheet

Concept 2022 Q1 2021 Q4 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $711.9M $715.8M $1.685M
YoY Change 42136.77% 422.55%
Cash & Equivalents $208.0M $521.8M $89.97M
Short-Term Investments $503.9M $194.0M
Other Short-Term Assets $11.76M $16.26M $638.2K
YoY Change 1742.74%
Inventory
Prepaid Expenses
Receivables $22.05M $29.67M
Other Receivables $0.00 $0.00
Total Short-Term Assets $745.7M $761.7M $2.324M
YoY Change 31991.5% 360.67%
LONG-TERM ASSETS
Property, Plant & Equipment $12.89M $12.55M
YoY Change 119.39%
Goodwill $1.211M $1.211M
YoY Change 0.0%
Intangibles $4.385M $4.835M
YoY Change -30.8%
Long-Term Investments $416.3M
YoY Change
Other Assets $304.0K $330.0K $654.3K
YoY Change -53.54% -52.86%
Total Long-Term Assets $76.52M $78.34M $417.0M
YoY Change -81.65% 49.53%
TOTAL ASSETS
Total Short-Term Assets $745.7M $761.7M $2.324M
Total Long-Term Assets $76.52M $78.34M $417.0M
Total Assets $822.2M $840.1M $419.3M
YoY Change 96.08% 285.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.554M $6.163M $497.2K
YoY Change 614.75% 83.75%
Accrued Expenses $20.63M $15.44M $94.83K
YoY Change 21655.77% 2.97%
Deferred Revenue $3.386M $3.388M
YoY Change 31.06%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $34.81M $33.50M $717.1K
YoY Change 4753.99% 4.1%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $59.73M $61.60M $14.57M
YoY Change 309.87%
Total Long-Term Liabilities $59.73M $61.60M $14.57M
YoY Change 309.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $34.81M $33.50M $717.1K
Total Long-Term Liabilities $59.73M $61.60M $14.57M
Total Liabilities $94.53M $95.10M $15.29M
YoY Change 518.3% 38.96%
SHAREHOLDERS EQUITY
Retained Earnings -$513.3M -$480.3M
YoY Change 24.76%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $727.7M $745.0M -$309.2M
YoY Change
Total Liabilities & Shareholders Equity $822.2M $840.1M $419.3M
YoY Change 96.08% 285.81%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021 Q1
OPERATING ACTIVITIES
Net Income -$32.95M -$82.39M -$25.14M
YoY Change 31.06%
Depreciation, Depletion And Amortization $1.330M $4.172M $1.083M
YoY Change 22.81%
Cash From Operating Activities -$5.513M -$49.49M -$8.750M
YoY Change -36.99%
INVESTING ACTIVITIES
Capital Expenditures $637.0K -$8.846M $1.894M
YoY Change -66.37%
Acquisitions
YoY Change
Other Investing Activities -$310.9M $275.7M $10.85M
YoY Change -2965.47%
Cash From Investing Activities -$311.5M $266.8M $8.956M
YoY Change -3578.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $12.20M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $3.136M 218.9M $4.928M
YoY Change -36.36%
NET CHANGE
Cash From Operating Activities -$5.513M -49.49M -$8.750M
Cash From Investing Activities -$311.5M 266.8M $8.956M
Cash From Financing Activities $3.136M 218.9M $4.928M
Net Change In Cash -$313.8M 436.2M $5.224M
YoY Change -6107.73%
FREE CASH FLOW
Cash From Operating Activities -$5.513M -$49.49M -$8.750M
Capital Expenditures $637.0K -$8.846M $1.894M
Free Cash Flow -$6.150M -$40.65M -$10.64M
YoY Change -42.22%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001846069
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-40246
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
Nextdoor Holdings, Inc
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-1776836
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
420 Taylor Street
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
San Francisco
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94102
CY2022Q1 dei City Area Code
CityAreaCode
(415)
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
344-0333
CY2022Q1 dei Security12b Title
Security12bTitle
Class A common stock, par value $0.0001 per share
CY2022Q1 dei Trading Symbol
TradingSymbol
KIND
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
207968000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
521812000 USD
CY2022Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
503899000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
193999000 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
312000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
425000 USD
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
22051000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
29673000 USD
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11760000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
16259000 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
745678000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
761743000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12886000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12545000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
57735000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
59422000 USD
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4385000 USD
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4835000 USD
CY2022Q1 us-gaap Goodwill
Goodwill
1211000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
1211000 USD
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
304000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
330000 USD
CY2022Q1 us-gaap Assets
Assets
822199000 USD
CY2021Q4 us-gaap Assets
Assets
840086000 USD
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3554000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6163000 USD
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7286000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7131000 USD
CY2022Q1 kvsb Deferred Compensation Share Based Arrangements Liability Unvested Restricted Stock Current
DeferredCompensationShareBasedArrangementsLiabilityUnvestedRestrictedStockCurrent
3335000 USD
CY2021Q4 kvsb Deferred Compensation Share Based Arrangements Liability Unvested Restricted Stock Current
DeferredCompensationShareBasedArrangementsLiabilityUnvestedRestrictedStockCurrent
4765000 USD
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20631000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15444000 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
34806000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
33503000 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
59727000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
61598000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
94533000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
95101000 USD
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1242955000 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1225815000 USD
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2041000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-529000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-513287000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-480339000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
727666000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
744985000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
822199000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
840086000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
51000000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34387000 USD
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
9055000 USD
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
6337000 USD
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28960000 USD
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20820000 USD
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
31061000 USD
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
22894000 USD
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15150000 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9329000 USD
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
84226000 USD
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
59380000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-33226000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-24993000 USD
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
491000 USD
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
40000 USD
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-185000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-148000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-32920000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25101000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
39000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-32948000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-25140000 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
381877000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
381877000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
97873000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
97873000 shares
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-32948000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-25140000 USD
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
74000 USD
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
90000 USD
CY2022Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-1586000 USD
CY2021Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
3000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1512000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
93000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-34460000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-25047000 USD
CY2021Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
744985000 USD
CY2022Q1 kvsb Adjustment To Additional Paid In Capital Tax Withholdings On Release Of Awards
AdjustmentToAdditionalPaidInCapitalTaxWithholdingsOnReleaseOfAwards
695000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4145000 USD
CY2022Q1 kvsb Adjustments To Additional Paid In Capital Early Vesting Of Stock Options
AdjustmentsToAdditionalPaidInCapitalEarlyVestingOfStockOptions
118000 USD
CY2022Q1 kvsb Adjustments To Additional Paid In Capital Vesting Of Restricted Stock Awards
AdjustmentsToAdditionalPaidInCapitalVestingOfRestrictedStockAwards
1429000 USD
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12144000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1512000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-32948000 USD
CY2022Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2022Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
727666000 USD
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
190477000 shares
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
447166000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-297856000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4928000 USD
CY2021Q1 kvsb Adjustments To Additional Paid In Capital Early Vesting Of Stock Options
AdjustmentsToAdditionalPaidInCapitalEarlyVestingOfStockOptions
88000 USD
CY2021Q1 kvsb Adjustments To Additional Paid In Capital Vesting Of Restricted Stock Awards
AdjustmentsToAdditionalPaidInCapitalVestingOfRestrictedStockAwards
1430000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7212000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
93000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-25140000 USD
CY2021Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
190477000 shares
CY2021Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
447166000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-309245000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-32948000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-25140000 USD
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1330000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1083000 USD
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
12144000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7212000 USD
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-221000 USD
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-97000 USD
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
582000 USD
CY2021Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-125000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-7843000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5092000 USD
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4499000 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3000 USD
CY2022Q1 kvsb Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-1687000 USD
CY2021Q1 kvsb Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-1641000 USD
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-26000 USD
CY2021Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-389000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3143000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
321000 USD
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1716000 USD
CY2021Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-863000 USD
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
5568000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1484000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5513000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8750000 USD
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
637000 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1894000 USD
CY2022Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
318245000 USD
CY2021Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
4395000 USD
CY2022Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
7342000 USD
CY2021Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
15245000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-311540000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
8956000 USD
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4145000 USD
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4928000 USD
CY2022Q1 kvsb Payment Of Transaction Costs Related To Reverse Recapitalization
PaymentOfTransactionCostsRelatedToReverseRecapitalization
314000 USD
CY2021Q1 kvsb Payment Of Transaction Costs Related To Reverse Recapitalization
PaymentOfTransactionCostsRelatedToReverseRecapitalization
0 USD
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
695000 USD
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3136000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4928000 USD
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
73000 USD
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
90000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-313844000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5224000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
521812000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
84743000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
207968000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
89967000 USD
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
135000 USD
CY2022Q1 kvsb Vesting Of Restricted Stock And Early Exercised Stock Options
VestingOfRestrictedStockAndEarlyExercisedStockOptions
1547000 USD
CY2021Q1 kvsb Vesting Of Restricted Stock And Early Exercised Stock Options
VestingOfRestrictedStockAndEarlyExercisedStockOptions
1518000 USD
CY2022Q1 kvsb Lease Liabilities Arising From Obtaining Right Of Use Assets
LeaseLiabilitiesArisingFromObtainingRightOfUseAssets
0 USD
CY2021Q1 kvsb Lease Liabilities Arising From Obtaining Right Of Use Assets
LeaseLiabilitiesArisingFromObtainingRightOfUseAssets
34971000 USD
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
584000 USD
CY2021Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1589000 USD
CY2022Q1 kvsb Number Of Members Of Board Of Directors
NumberOfMembersOfBoardOfDirectors
10 member
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Estimates include, but are not limited to, valuation of financial instruments, valuation of common stock through the date of the Reverse Recapitalization, valuation of stock-based awards, revenue recognition, collectability of accounts receivable, valuation of acquired intangible assets and goodwill, useful lives of intangible assets, useful lives of property and equipment, the incremental borrowing rate applied in lease accounting, income taxes and deferred income tax assets and associated valuation allowances. The Company bases these estimates and assumptions on historical experience and various other assumptions that it considers reasonable. The actual results could differ materially from these estimates.</span></div>
CY2022Q1 kvsb Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
3.1057
CY2021Q3 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
270000000 USD
CY2021Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
27000000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
382957639 shares
CY2021Q4 kvsb Proceeds From Reverse Recapitalization Transaction
ProceedsFromReverseRecapitalizationTransaction
628500000 USD
CY2021Q4 kvsb Cash Acquired Through Reverse Recapitalization Trust Account
CashAcquiredThroughReverseRecapitalizationTrustAccount
416400000 USD
CY2021Q4 kvsb Cash Acquired Through Reverse Recapitalization Operating Cash Account
CashAcquiredThroughReverseRecapitalizationOperatingCashAccount
200000 USD
CY2021Q4 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
270000000 USD
CY2021Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
12200000 USD
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3400000 USD
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3400000 USD
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2900000 USD
CY2021Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1100000 USD
CY2022Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
505500000 USD
CY2022Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
48000 USD
CY2022Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1649000 USD
CY2022Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
503899000 USD
CY2022Q1 kvsb Cash Equivalents At Carrying Value And Debt Securities Available For Sale Amortized Cost
CashEquivalentsAtCarryingValueAndDebtSecuritiesAvailableForSaleAmortizedCost
648752000 USD
CY2022Q1 kvsb Cash Equivalents At Carrying Value And Debt Securities Available For Sale Unrealized Gain
CashEquivalentsAtCarryingValueAndDebtSecuritiesAvailableForSaleUnrealizedGain
51000 USD
CY2022Q1 kvsb Cash Equivalents At Carrying Value And Debt Securities Available For Sale Unrealized Loss
CashEquivalentsAtCarryingValueAndDebtSecuritiesAvailableForSaleUnrealizedLoss
1652000 USD
CY2022Q1 kvsb Cash Equivalents Fair Value Disclosure And Debt Securities Available For Sale Current
CashEquivalentsFairValueDisclosureAndDebtSecuritiesAvailableForSaleCurrent
647151000 USD
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
194016000 USD
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
24000 USD
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
41000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
193999000 USD
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
24000 USD
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
41000 USD
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis
430204000 USD
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
429237000 USD
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis
75296000 USD
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
74662000 USD
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4154000 USD
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
505500000 USD
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
503899000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
137077000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
137043000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
56939000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
56956000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
194016000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
193999000 USD
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3375000 USD
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3386000 USD
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3388000 USD
CY2022Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
1156000 USD
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
879000 USD
CY2022Q1 kvsb Deferred Compensation Share Based Arrangements Liability Unvested Stock Options Current
DeferredCompensationShareBasedArrangementsLiabilityUnvestedStockOptionsCurrent
572000 USD
CY2021Q4 kvsb Deferred Compensation Share Based Arrangements Liability Unvested Stock Options Current
DeferredCompensationShareBasedArrangementsLiabilityUnvestedStockOptionsCurrent
690000 USD
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
11363000 USD
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7112000 USD
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20631000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15444000 USD
CY2022Q1 kvsb Common Stock Subject To Repurchase Liability Current
CommonStockSubjectToRepurchaseLiabilityCurrent
600000 USD
CY2021Q4 kvsb Common Stock Subject To Repurchase Liability Current
CommonStockSubjectToRepurchaseLiabilityCurrent
700000 USD
CY2022Q1 kvsb Common Stock Subject To Repurchase Nonvested Number Of Shares
CommonStockSubjectToRepurchaseNonvestedNumberOfShares
348884 shares
CY2021Q4 kvsb Common Stock Subject To Repurchase Nonvested Number Of Shares
CommonStockSubjectToRepurchaseNonvestedNumberOfShares
421594 shares
CY2022Q1 kvsb Restricted Stock Subject To Repurchase Liability
RestrictedStockSubjectToRepurchaseLiability
3300000 USD
CY2021Q4 kvsb Restricted Stock Subject To Repurchase Liability
RestrictedStockSubjectToRepurchaseLiability
4800000 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
58278000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.35
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y1M6D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
322799000 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
5817000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.05
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2259000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.84
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
1925000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
2.95
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.71
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y1M6D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
199094000 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
59911000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
24870000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.79
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y6M
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
104361000 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.28
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.70
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
3796345 shares
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
3952096 shares
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
2.75
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
1.90
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
9800000 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
5500000 USD
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12144000 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7212000 USD
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
144800000 USD
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y3M18D
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-25140000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-25140000 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
97873000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
97873000 shares
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
69196000 shares
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
259946000 shares
CY2022Q1 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
600000 USD
CY2021Q1 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
500000 USD
CY2022Q1 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
51000000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34387000 USD

Files In Submission

Name View Source Status
0001846069-22-000024-index-headers.html Edgar Link pending
0001846069-22-000024-index.html Edgar Link pending
0001846069-22-000024.txt Edgar Link pending
0001846069-22-000024-xbrl.zip Edgar Link pending
a311certificationofprincip.htm Edgar Link pending
a312certificationofprincip.htm Edgar Link pending
a321peosection1350certific.htm Edgar Link pending
a322cfosection1350certific.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
kvsb-20220331.htm Edgar Link pending
kvsb-20220331.xsd Edgar Link pending
kvsb-20220331_cal.xml Edgar Link unprocessable
kvsb-20220331_def.xml Edgar Link unprocessable
kvsb-20220331_g1.jpg Edgar Link pending
kvsb-20220331_g2.jpg Edgar Link pending
kvsb-20220331_g3.jpg Edgar Link pending
kvsb-20220331_g4.jpg Edgar Link pending
kvsb-20220331_g5.jpg Edgar Link pending
kvsb-20220331_g6.jpg Edgar Link pending
kvsb-20220331_htm.xml Edgar Link completed
kvsb-20220331_lab.xml Edgar Link unprocessable
kvsb-20220331_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending